Thank you for visiting the FAST UK website. On behalf of the entire FAST family, we want to extend a warm welcome to you.
FAST was founded in 2008 with an urgent mission: cure Angelman syndrome. Today, with operations in the United States, Australia, Canada, Great Britain, France and Italy. Our organisation is the largest non-governmental funder of Angelman syndrome research, and we take this responsibility seriously.
All financial gifts are invested wisely, and less than 4 percent of expenses are spent on general and administrative costs. Our noteworthy efficiency means there is more money to support critical research. And we don’t just write cheques. FAST has set the research agenda for Angelman syndrome by bringing together a multidisciplinary team of more than two-dozen scientists from top research universities and pharmaceutical companies to join forces on a focused path to a cure.
Now is the time for action. FAST’s roadmap to a cure is bold, ambitious, and, with your help, achievable. Please join us by making a financial gift, spreading the word with friends and family members, and fundraising to help us cross the finish line. Our ultimate goal is to successfully complete this race by finding a cure.